annual D&A:
$1.10M+$569.00K(+107.97%)Summary
- As of today (September 17, 2025), MDGL annual depreciation & amortization is $1.10 million, with the most recent change of +$569.00 thousand (+107.97%) on December 31, 2024.
- During the last 3 years, MDGL annual D&A has risen by +$691.00 thousand (+170.62%).
- MDGL annual D&A is now -70.01% below its all-time high of $3.65 million, reached on December 31, 2006.
Performance
MDGL Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$377.00K-$2000.00(-0.53%)Summary
- As of today (September 17, 2025), MDGL quarterly depreciation & amortization is $377.00 thousand, with the most recent change of -$2000.00 (-0.53%) on June 30, 2025.
- Over the past year, MDGL quarterly D&A has increased by +$110.00 thousand (+41.20%).
- MDGL quarterly D&A is now -57.11% below its all-time high of $879.00 thousand, reached on December 31, 2007.
Performance
MDGL quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.42M+$110.00K(+8.42%)Summary
- As of today (September 17, 2025), MDGL TTM depreciation & amortization is $1.42 million, with the most recent change of +$110.00 thousand (+8.42%) on June 30, 2025.
- Over the past year, MDGL TTM D&A has increased by +$705.00 thousand (+99.02%).
- MDGL TTM D&A is now -57.71% below its all-time high of $3.35 million, reached on December 31, 2007.
Performance
MDGL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
MDGL Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +108.0% | +41.2% | +99.0% |
| 3 y3 years | +170.6% | +242.7% | +237.4% |
| 5 y5 years | +878.6% | +227.8% | +378.7% |
MDGL Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +170.6% | -0.5% | +242.7% | at high | +237.4% |
| 5 y | 5-year | at high | +878.6% | -0.5% | +323.6% | at high | +378.7% |
| alltime | all time | -70.0% | >+9999.0% | -57.1% | +4088.9% | -57.7% | >+9999.0% |
MDGL Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $377.00K(-0.5%) | $1.42M(+8.4%) |
| Mar 2025 | - | $379.00K(+4.4%) | $1.31M(+19.3%) |
| Dec 2024 | $1.10M(+108.0%) | $363.00K(+21.8%) | $1.10M(+25.3%) |
| Sep 2024 | - | $298.00K(+11.6%) | $875.00K(+22.9%) |
| Jun 2024 | - | $267.00K(+58.9%) | $712.00K(+24.7%) |
| Mar 2024 | - | $168.00K(+18.3%) | $571.00K(+8.3%) |
| Dec 2023 | $527.00K(+12.8%) | $142.00K(+5.2%) | $527.00K(+2.5%) |
| Sep 2023 | - | $135.00K(+7.1%) | $514.00K(+2.8%) |
| Jun 2023 | - | $126.00K(+1.6%) | $500.00K(+3.3%) |
| Mar 2023 | - | $124.00K(-3.9%) | $484.00K(+3.6%) |
| Dec 2022 | $467.00K(+15.3%) | $129.00K(+6.6%) | $467.00K(+5.2%) |
| Sep 2022 | - | $121.00K(+10.0%) | $444.00K(+5.7%) |
| Jun 2022 | - | $110.00K(+2.8%) | $420.00K(+5.3%) |
| Mar 2022 | - | $107.00K(+0.9%) | $399.00K(-1.5%) |
| Dec 2021 | $405.00K(-14.0%) | $106.00K(+9.3%) | $405.00K(-2.4%) |
| Sep 2021 | - | $97.00K(+9.0%) | $415.00K(-4.2%) |
| Jun 2021 | - | $89.00K(-21.2%) | $433.00K(-5.7%) |
| Mar 2021 | - | $113.00K(-2.6%) | $459.00K(-2.5%) |
| Dec 2020 | $471.00K(+320.5%) | $116.00K(+0.9%) | $471.00K(+23.0%) |
| Sep 2020 | - | $115.00K(0.0%) | $383.00K(+29.4%) |
| Jun 2020 | - | $115.00K(-8.0%) | $296.00K(+41.6%) |
| Mar 2020 | - | $125.00K(+346.4%) | $209.00K(+86.6%) |
| Dec 2019 | $112.00K(+16.7%) | $28.00K(0.0%) | $112.00K(+2.8%) |
| Sep 2019 | - | $28.00K(0.0%) | $109.00K(+3.8%) |
| Jun 2019 | - | $28.00K(0.0%) | $105.00K(+4.0%) |
| Mar 2019 | - | $28.00K(+12.0%) | $101.00K(+5.2%) |
| Dec 2018 | $96.00K(+24.7%) | $25.00K(+4.2%) | $96.00K(-26.7%) |
| Sep 2018 | - | $24.00K(0.0%) | $131.00K(+12.9%) |
| Jun 2018 | - | $24.00K(+4.3%) | $116.00K(+26.1%) |
| Mar 2018 | - | $23.00K(-61.7%) | $92.00K(+33.3%) |
| Dec 2017 | $77.00K(>+9900.0%) | $60.00K(+566.7%) | $69.00K(+666.7%) |
| Sep 2017 | - | $9000.00(-90.6%) | $9000.00(-98.1%) |
| Dec 2016 | $200.00(>+9900.0%) | - | - |
| Jun 2016 | - | $96.00K(+108.7%) | $467.00K(-13.4%) |
| Mar 2016 | - | $46.00K(-71.1%) | $539.00K(-18.6%) |
| Dec 2015 | $0.00 | $159.00K(-4.2%) | $662.00K(-1.5%) |
| Sep 2015 | - | $166.00K(-1.2%) | $672.00K(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | $168.00K(-0.6%) | $673.00K(-0.1%) |
| Mar 2015 | - | $169.00K(0.0%) | $674.00K(+0.1%) |
| Dec 2014 | $673.00K(+30.4%) | $169.00K(+1.2%) | $673.00K(+33.5%) |
| Sep 2014 | - | $167.00K(-1.2%) | $504.00K(+49.6%) |
| Jun 2014 | - | $169.00K(+0.6%) | $337.00K(+15.0%) |
| Mar 2014 | - | $168.00K(+34.4%) | $293.00K(-42.5%) |
| Dec 2013 | $516.00K(-30.1%) | - | - |
| Jun 2013 | - | $125.00K(+25.0%) | $510.00K(-16.1%) |
| Mar 2013 | - | $100.00K(-13.0%) | $608.00K(-17.6%) |
| Dec 2012 | $738.00K(-49.6%) | $115.00K(-32.4%) | $738.00K(-19.3%) |
| Sep 2012 | - | $170.00K(-23.8%) | $914.00K(-16.5%) |
| Jun 2012 | - | $223.00K(-3.0%) | $1.09M(-12.8%) |
| Mar 2012 | - | $230.00K(-21.0%) | $1.25M(-14.3%) |
| Dec 2011 | $1.46M(-24.3%) | $291.00K(-16.9%) | $1.46M(-10.5%) |
| Sep 2011 | - | $350.00K(-8.9%) | $1.64M(-7.0%) |
| Jun 2011 | - | $384.00K(-12.5%) | $1.76M(-5.3%) |
| Mar 2011 | - | $439.00K(-5.2%) | $1.86M(-3.9%) |
| Dec 2010 | $1.93M(-21.5%) | $463.00K(-2.1%) | $1.93M(-2.6%) |
| Sep 2010 | - | $473.00K(-1.9%) | $1.99M(-6.2%) |
| Jun 2010 | - | $482.00K(-6.4%) | $2.12M(-7.4%) |
| Mar 2010 | - | $515.00K(0.0%) | $2.29M(-7.2%) |
| Dec 2009 | $2.46M(-9.3%) | $515.00K(-14.7%) | $2.46M(-6.3%) |
| Sep 2009 | - | $604.00K(-7.2%) | $2.63M(-4.5%) |
| Jun 2009 | - | $651.00K(-6.1%) | $2.75M(+0.8%) |
| Mar 2009 | - | $693.00K(+1.6%) | $2.73M(+0.6%) |
| Dec 2008 | $2.72M(-18.9%) | $682.00K(-6.4%) | $2.72M(-6.8%) |
| Sep 2008 | - | $729.00K(+16.1%) | $2.91M(-3.2%) |
| Jun 2008 | - | $628.00K(-7.4%) | $3.01M(-6.8%) |
| Mar 2008 | - | $678.00K(-22.9%) | $3.23M(-3.6%) |
| Dec 2007 | $3.35M(-8.3%) | $879.00K(+6.4%) | $3.35M(+1.6%) |
| Sep 2007 | - | $826.00K(-2.6%) | $3.30M(+33.4%) |
| Jun 2007 | - | $848.00K(+6.3%) | $2.47M(+52.2%) |
| Mar 2007 | - | $798.00K(-3.5%) | $1.63M(+96.5%) |
| Dec 2006 | $3.65M(+48.9%) | $827.00K(+92.3%) | $827.00K(+92.3%) |
| Dec 2005 | $2.46M(+58.7%) | - | - |
| Mar 2005 | - | $430.00K | $430.00K |
| Dec 2004 | $1.55M(+53.8%) | - | - |
| Dec 2003 | $1.01M | - | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual depreciation & amortization?
The current annual D&A of MDGL is $1.10M
What is the all time high annual D&A for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $3.65M
What is Madrigal Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, MDGL annual depreciation & amortization has changed by +$569.00K (+107.97%)
What is Madrigal Pharmaceuticals, Inc. quarterly depreciation & amortization?
The current quarterly D&A of MDGL is $377.00K
What is the all time high quarterly D&A for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $879.00K
What is Madrigal Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, MDGL quarterly depreciation & amortization has changed by +$110.00K (+41.20%)
What is Madrigal Pharmaceuticals, Inc. TTM depreciation & amortization?
The current TTM D&A of MDGL is $1.42M
What is the all time high TTM D&A for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $3.35M
What is Madrigal Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, MDGL TTM depreciation & amortization has changed by +$705.00K (+99.02%)